EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen‐specific Immunity Against Tumor

Hongze Ren, Anqi Zhu, Wei Yang, Yiwen Jia, Hui Cheng, Ye Wu, Zhengqi Tang, Weifan Ye, Mayu Sun, Yujie Xie, Meihua Yu, Yu Chen iD

Advanced Science · 2024

DOI: 10.1002/advs.202405729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Hongze Ren und 11 weiteren Autor:innen. Beteiligte Einrichtung: Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Cancer Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai University Animal Ethics Committee, National Natural Science Foundation of China, Shanghai Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic efficacy of vaccines for treating cancers in clinics remains limited. Here, a rationally designed cancer vaccine by placing immunogenically differential and clinically approved aluminum (Al) or manganese (Mn) in a 2D nanosheet (NS) architecture together with antigens is reported. Structurally optimal NS with a high molar ratio of Mn to Al (MANS‐H) features distinctive immune modulation, markedly promoting the influx of heterogeneous innate immune cells at the injection site. Stimulation of multiple subsets of dendritic cells (DCs) significantly increases the levels, subtypes, and functionalities of antigen‐specific T cells. MANS‐H demonstrates even greater effectiveness in the production of antigen‐specific antibodies than the commercial adjuvant (Alhydrogel) by priming T helper (Th)2 cells rather than T follicular helper (Tfh) cells. Beyond humoral immunity, MANS‐H evokes high frequencies of antigen‐specific Th1 and CD8 + cell immunity, which are comparable with Quil‐A that is widely used in veterinary vaccines. Immunized mice with MANS‐H adjuvanted vaccines exert strong potency in tumor regression by promoting effector T cells infiltrating at tumor and overcoming tumor resistance in multiple highly aggressive tumor models. The engineered immunogen with an intriguing NS architecture and safe immunopotentiators offers the next clinical advance in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adjuvants, ImmunologicCancer VaccinesAnimalsMiceManganeseNeoplasmsDisease Models, AnimalDendritic CellsAluminumMice, Inbred C57BLFemale

Stichwörter der Autor:innen

2D nanosheetsantigen‐specific immunitycancer immunotherapycancer vaccinesmaterial adjuvants

Substanzen

Adjuvants, ImmunologicCancer VaccinesManganeseAluminum

Autor:innen und Institutionen

  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
  • School of medicine, Shanghai University, Shanghai, 200444, China.
  • Department of Medical Ultrasound, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200070, China.
  • Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200092, China.
  • Laboratory Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

ORCID-Profile: Yu Chen

Förderung

  • Shanghai University Animal Ethics Committee
  • National Natural Science Foundation of China
  • Shanghai Science and Technology Program
  • Shanghai Pujiang Program
  • Wenzhou Basic Scientific Research Project
  • Shanghai Excellent Overseas Young Scientists
  • Shanghai Education Development Foundation
  • Shanghai Municipal Education Commission

Zitieren

APA

Ren, H., Zhu, A., Yang, W., Jia, Y., Cheng, H., Wu, Y., Tang, Z., Ye, W., Sun, M., Xie, Y., Yu, M., & Chen, Y. (2024). 2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen‐specific Immunity Against Tumor. Advanced Science. https://doi.org/10.1002/advs.202405729

Vancouver

Ren H, Zhu A, Yang W, Jia Y, Cheng H, Wu Y, et al. 2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen‐specific Immunity Against Tumor. Advanced Science. 2024. doi:10.1002/advs.202405729

BibTeX
@article{Ren2024,
  author = {Ren, Hongze and Zhu, Anqi and Yang, Wei and Jia, Yiwen and Cheng, Hui and Wu, Ye and Tang, Zhengqi and Ye, Weifan and Sun, Mayu and Xie, Yujie and Yu, Meihua and Chen, Yu},
  title = {2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen‐specific Immunity Against Tumor},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202405729}
}
Kostenlos starten →